Clinical Trial Update: Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intensity-modulated radiotherapy with or without concurrent chemotherapy for stage II nasopharyngeal carcinoma. The trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN